Short Overview: Eosinophilic granulomatosis with polyangiitis (EGPA), formerly known as Churg-Strauss syndrome, is a rare autoimmune ... We are learning about the features of innate immunity, and one that is often overlooked is the complement system.
Newly Identified Pathway Explains Why 19597 -
Eosinophilic granulomatosis with polyangiitis (EGPA), formerly known as Churg-Strauss syndrome, is a rare autoimmune ... We are learning about the features of innate immunity, and one that is often overlooked is the complement system. Join us for a dynamic Mechanisms to Medicine symposium featuring expert panelists Drs.
Important details found
- Eosinophilic granulomatosis with polyangiitis (EGPA), formerly known as Churg-Strauss syndrome, is a rare autoimmune ...
- We are learning about the features of innate immunity, and one that is often overlooked is the complement system.
- Join us for a dynamic Mechanisms to Medicine symposium featuring expert panelists Drs.
- Pieter Sonneveld, MD, PhD, Erasmus MC, Rotterdam, The Netherlands, discusses how the
- Przytycka is a Senior Investigator in NLM's Computational Biology Branch.
Why this topic is useful
The goal of this page is to make Newly Identified Pathway Explains Why 19597 easier to scan, compare, and understand before opening related resources.
Frequently Asked Questions
What should readers check next?
Readers should check related pages, official references, or updated sources when details matter.
Why are related topics included?
Related topics help readers compare nearby references and understand the broader subject.
What is this page about?
This page summarizes Newly Identified Pathway Explains Why 19597 and connects it with related entries, references, and supporting context.
